Bristol Myers Squibb (BMY) Net Income towards Common Stockholders Growth (5y) (2014 - 2026)
| Date | Value |
| Mar 31, 2026 |
6.44% |
| Dec 31, 2025 |
16.08% |
| Sep 30, 2025 |
3.98% |
| Jun 30, 2025 |
61.52% |
| Mar 31, 2025 |
37.75% |
| Dec 31, 2024 |
15.61% |
| Sep 30, 2024 |
-1.69% |
| Jun 30, 2024 |
4.04% |
| Mar 31, 2024 |
-56.44% |
| Dec 31, 2023 |
9.96% |
| Sep 30, 2023 |
1.42% |
| Jun 30, 2023 |
49.19% |
| Mar 31, 2023 |
10.40% |
| Dec 31, 2022 |
23.14% |
| Sep 30, 2022 |
17.27% |
| Jun 30, 2022 |
12.30% |
| Mar 31, 2022 |
-1.83% |
| Dec 31, 2021 |
26.65% |
| Sep 30, 2021 |
7.18% |
| Jun 30, 2021 |
-0.65% |
| Mar 31, 2021 |
13.50% |
| Dec 31, 2020 |
-96.31% |
| Sep 30, 2020 |
27.50% |
| Jun 30, 2020 |
12.09% |
| Mar 31, 2020 |
-22.76% |
| Dec 31, 2019 |
-61.99% |
| Sep 30, 2019 |
13.33% |
| Jun 30, 2019 |
36.51% |
| Mar 31, 2019 |
12.98% |
| Dec 31, 2018 |
10.22% |
| Sep 30, 2018 |
20.68% |
| Jun 30, 2018 |
-11.85% |
| Mar 31, 2018 |
18.84% |
| Dec 31, 2017 |
-36.15% |
| Sep 30, 2017 |
24.71% |
| Jun 30, 2017 |
-6.07% |
| Mar 31, 2017 |
-1.03% |
| Dec 31, 2016 |
-11.22% |
| Sep 30, 2016 |
-5.03% |
| Jun 30, 2016 |
-4.69% |
| Mar 31, 2016 |
-5.30% |
| Dec 31, 2015 |
23.50% |
| Sep 30, 2015 |
-16.26% |
| Jun 30, 2015 |
-18.13% |
| Mar 31, 2015 |
-0.83% |
| Dec 31, 2014 |
-15.03% |
| Sep 30, 2014 |
49.25% |
| Jun 30, 2014 |
-20.27% |
| Mar 31, 2014 |
287.88% |